Gong, Inna Y <br/><br/>
Clarifying the importance of CYP2C19 and PON1 in the mechanism of clopidogrel bioactivation and in vivo antiplatelet response.  [electronic resource] 

 -  European heart journal  Nov 2012 
 - 2856-2464a p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1522-9645 
<br/><br/><label>Standard No.: </label>10.1093/eurheartj/ehs042  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Area Under Curve<br/>Aryl Hydrocarbon Hydroxylases--genetics<br/>Aryldialkylphosphatase--genetics<br/>Biotransformation--drug effects<br/>Clopidogrel<br/>Cytochrome P-450 CYP2C19<br/>Cytochrome P-450 CYP3A--drug effects<br/>Enzyme Inhibitors--pharmacokinetics<br/>Humans<br/>Midazolam--pharmacokinetics<br/>Middle Aged<br/>Platelet Aggregation--drug effects<br/>Platelet Aggregation Inhibitors--pharmacokinetics<br/>Polymorphism, Genetic--genetics<br/>Ticlopidine--analogs & derivatives<br/>Young Adult